TriSalus Life Sciences, Inc. TLSI Contingent Consideration Liability (Non-Current)
Contingent Consideration Liability (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s contingent consideration liability (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s contingent consideration liability (non-current)?
- TriSalus Life Sciences, Inc. (TLSI) reported contingent consideration liability (non-current) of $2.74M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s contingent consideration liability (non-current) changed year-over-year?
- TriSalus Life Sciences, Inc.'s contingent consideration liability (non-current) decreased by 66.6% year-over-year, from $8.22M to $2.74M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s contingent consideration liability (non-current)?
- Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s contingent consideration liability (non-current) has grown at a -26.2% compound annual growth rate (CAGR), from $18.63M to $10.14M.
- What does contingent consideration liability (non-current) mean?
- This represents the estimated fair value of future payments to be made to sellers in a business combination, contingent upon the achievement of specific future performance targets. As a non-current liability, it indicates obligations that are expected to be settled after one year. It provides insight into the company's acquisition strategy and the potential future cash impact of past growth initiatives.